Log In
Print
BCIQ
Print
Print this Print this
 

Aciphex Sprinkle (delayed-release rabeprazole)

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionExtended-release 50 mg formulation of rabeprazole, a protein pump inhibitor (PPI)
Molecular Target H+/K ATPase pump
Mechanism of ActionH+/K+ ATPase pump inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationGastroesophageal reflux disease (GERD)
Indication DetailsHeal and maintain healing of erosive gastroesophageal reflux disease (GERD) and treat symptomatic non-erosive GERD; Treat gastroesophageal reflux disease (GERD) for 12 weeks in children ages 1-11; Treatment and maintenance treatment of erosive gastroesophageal reflux disease (GERD) and to treat symptomatic GERD
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today